StockNews.AI
AWH
StockNews.AI
125 days

Aspira Women's Health Inc. Announces Receipt of Delisting Notification from Nasdaq

1. Nasdaq plans to delist AWH for failing listing standards. 2. AWH did not maintain required stockholders' equity.

2m saved
Insight
Article

FAQ

Why Very Bearish?

The delisting announcement typically leads to a significant drop in stock price. Similar cases show stocks often suffer long-term losses post-delisting.

How important is it?

The delisting impacts investor confidence and market perception directly affecting AWH's profitability. Historical context shows companies delisted struggle to recover investor trust, directly affecting share price.

Why Short Term?

Immediate market reaction expected due to delisting notice; stock prices usually decline quickly. Past delistings negatively affected companies within days.

Related Companies

AWH
SHELTON, CT / ACCESS Newswire / April 16, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that on April 15, 2025, the Company received written notice (the "Notice") from the Office of General Counsel of The Nasdaq Stock Market ("Nasdaq") indicating that the Nasdaq Hearings Panel has determined to delist the Company's shares from Nasdaq due to the Company's failure to meet Nasdaq's continued listing standards. As previously disclosed, the Company has not been compliant with the requirements under Nasdaq Listing Rule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders' equity for continued listing on the Nasdaq Capital Market.

Related News